Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
The goal to establish the African Medicines Agency (AMA) in 2018 as a Specialised Agency…
On Thursday 23 February 2017 in Nairobi, Kenya, the GE healthymagination Mother and Child Programme…
The growing incidence of Western lifestyle diseases such as cardiovascular disease (CVD), cancer, diabetes and…
Five years ago today, the heads of some of the world’s largest pharmaceutical groups gathered…
After decades of shadowboxing with the human immunodeficiency virus, researchers were encouraged four years ago…
Africa is uncharted territory when it comes to sequencing genomes and studying genetic causes for diseases that…
Strong global and national leadership is needed as lack of access to essential medicines threatens…
The next Ebola outbreak could have a prime-boost vaccine available, particularly for health workers and vulnerable…
The government has reaffirmed its commitment to develop and implement regional pharmaceutical and health technologies…